Ke YD - Search Results

1

Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia.

Przybyla M, Stevens CH, van der Hoven J, Harasta A, Bi M, Ittner A, van Hummel A, Hodges JR, Piguet O, Karl T, Kassiou M, Housley GD, Ke YD, Ittner LM, van Eersel J. Przybyla M, et al. Among authors: ke yd. Neurosci Lett. 2016 Sep 19;631:24-29. doi: 10.1016/j.neulet.2016.08.007. Epub 2016 Aug 10. Neurosci Lett. 2016. PMID: 27521751

2

Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response.

Götz J, David D, Hoerndli F, Ke YD, Schonrock N, Wiesner A, Fath T, Bokhari L, Lim YA, Deters N, Ittner LM. Götz J, et al. Among authors: ke yd. Neurodegener Dis. 2008;5(3-4):179-81. doi: 10.1159/000113696. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322384 Review.

3

Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia.

Ittner LM, Fath T, Ke YD, Bi M, van Eersel J, Li KM, Gunning P, Götz J. Ittner LM, et al. Among authors: ke yd. Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15997-6002. doi: 10.1073/pnas.0808084105. Epub 2008 Oct 2. Proc Natl Acad Sci U S A. 2008. PMID: 18832465 Free PMC article.

4

Primary support cultures of hippocampal and substantia nigra neurons.

Fath T, Ke YD, Gunning P, Götz J, Ittner LM. Fath T, et al. Among authors: ke yd. Nat Protoc. 2009;4(1):78-85. doi: 10.1038/nprot.2008.199. Nat Protoc. 2009. PMID: 19131959

5

Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.

Ittner LM, Ke YD, Götz J. Ittner LM, et al. Among authors: ke yd. J Biol Chem. 2009 Jul 31;284(31):20909-16. doi: 10.1074/jbc.M109.014472. Epub 2009 Jun 2. J Biol Chem. 2009. PMID: 19491104 Free PMC article.

6

Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains.

van Eersel J, Bi M, Ke YD, Hodges JR, Xuereb JH, Gregory GC, Halliday GM, Götz J, Kril JJ, Ittner LM. van Eersel J, et al. Among authors: ke yd. J Neural Transm (Vienna). 2009 Oct;116(10):1243-51. doi: 10.1007/s00702-009-0293-y. Epub 2009 Aug 20. J Neural Transm (Vienna). 2009. PMID: 19693433

7

Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.

Ke YD, Delerue F, Gladbach A, Götz J, Ittner LM. Ke YD, et al. PLoS One. 2009 Nov 19;4(11):e7917. doi: 10.1371/journal.pone.0007917. PLoS One. 2009. PMID: 19936237 Free PMC article.

8

Dissecting toxicity of tau and beta-amyloid.

Götz J, Lim YA, Ke YD, Eckert A, Ittner LM. Götz J, et al. Among authors: ke yd. Neurodegener Dis. 2010;7(1-3):10-2. doi: 10.1159/000283475. Epub 2010 Feb 13. Neurodegener Dis. 2010. PMID: 20160450

9

Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.

Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T, Götz J. Schonrock N, et al. Among authors: ke yd. PLoS One. 2010 Jun 11;5(6):e11070. doi: 10.1371/journal.pone.0011070. PLoS One. 2010. PMID: 20552018 Free PMC article.

10

Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.

van Eersel J, Ke YD, Liu X, Delerue F, Kril JJ, Götz J, Ittner LM. van Eersel J, et al. Among authors: ke yd. Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13888-93. doi: 10.1073/pnas.1009038107. Epub 2010 Jul 19. Proc Natl Acad Sci U S A. 2010. PMID: 20643941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters